FIG. 3.

The dynamic changes of NK cell subsets during treatment. Eight patients were followed up to 24 weeks to assess the frequency of TRAIL⁺ or FasL⁺ NK cells. Anglicizing affect of different IFN on NK cells, to divide patients into 2 groups [standard interferon-α (IFN-α) groups and pegylated interferon (Peg-IFN-α) groups] and observe the changes of NK receptors. (A, B) The dynamic change of apoptosis-related ligands on NK cells during the treatment. (C, D) The dynamic change of NK cell activating receptors during the course of treatment in different groups (*P<0.5; **P<0.01; ***P<0.001).